FFL Flash Alerts - Matt Harmon explains why he doesn't care about the LA Rams offense in fantasy.
FFL Flash Alerts - Matt Harmon explains why he doesn't care about the LA Rams offense in fantasy.
"The Mandalorian" director explained that big Baby Yoda reveal.
Reddit has revealed its daily active user count for the first time, and it's nowhere near social media giants — but it's still important at 52 million.
The 1984 cult classic followed a janitor who is pushed into a vast of toxic waste and becomes a superhero named Toxie
Chinese state news agencies are reporting a successful landing of the Chang'e-5 lunar robotic lander, which will seek to return lunar rock samples back to Earth. The launch took off on November 23, and attained lunar orbit on November 28. It launched the lander vehicle on November 30, and the reports today from the China National Space Administration (CNSA) says that at shortly after 10 AM EST it achieved its goal of touching down on the Moon's surface intact.
Kirkland Lake, Ontario--(Newsfile Corp. - December 1, 2020) - RJK Explorations Ltd. (TSXV: RJX.A) (OTC: RJKAF) ("RJK" or "the Company") announces that it has granted today a total of 450,000 stock options to purchase Class A Subordinate Voting Shares in the capital of the Company ("Class A Shares") to directors, officers and consultants of the Company at an exercise price of $0.18 per Class A share, expiring on December 1, 2025. The closing ...
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Turquoise Hill Resources Limited ("Turquoise Hill" or the "Company") (NYSE: TRQ) between July 17, 2018, and July 31, 2019, inclusive (the "Class Period"). The lawsuit filed in the United States District Court for the Southern District of New York alleges violations of the Securities Exchange Act of 1934.
Natalie Portman will take over Thor from Chris Hemsworth in Thor: Love and Thunder
California Gov. Gavin Newsom warns of tougher stay-at-home order. Michigan Rep. John Chirkun tests positive. U.S. deaths top 268K. Latest COVID news.
(Bloomberg) -- An Ohio startup that helps hospitals automate routine tasks is now valued at $1.5 billion after a funding round led by Tiger Global Management.Olive AI Inc. received an investment of $225.5 million in the round, which included new investors Alphabet Inc.’s GV, Sequoia Capital, Dragoneer Investment Group and Transformation Partners. Existing investors General Catalyst and Drive Capital also joined the round.Columbus-based Olive has now raised about $385 million in financing in the past nine months and roughly $450 million since its inception in 2012.The company’s software is used by more than 600 hospitals in the U.S. to analyze data for insurance claims and supply chains.Chief Executive Officer Sean Lane said Olive’s customers are using its software to save money in a year in which the health-care business has struggled because of the coronavirus pandemic. “We’re part of their recovery plan from a cost-savings perspective,” Lane said.The startup is part of Ohio’s growing technology ecosystem. Auto insurance platform Root Inc., also based in Columbus, raised $724 million in an initial public offering in October.Lane said that he believes that launching in Ohio gave the company an advantage because there was less competition for hiring the best local talent. He said Olive has now expanded beyond the state and has a distributed workforce, something that will continue after the pandemic.The newly raised capital will be used for more hiring, as well as product development, he said.Olive will eventually hold an IPO, Lane said. “The inevitable future is going public.”(Corrects the amount raised by the company in the second paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
The price rise will take effect on 1 January when the cost of a second class stamp will rise 1p to 66p.
There are still Cyber Monday deals live on desks, chairs, keyboards, mice, computer monitors, printers and more essentials for your home office.
Qualivian Investment Partners recently released its Q3 2020 Investor Letter. In Q3 2020, the fund was up 9.3% and 9.1% on a gross and net basis versus the S&P’s 8.93% increase, outperforming by 0.3% and 0.2%. In October, we published an article revealing our exclusive interview with Qualivian Investment Partners’ co-founder Aamer Khan. You should check […]
SNY MLB Insider Andy Martino says he feels comfortable calling outfielder George Springer a top free agent target for the Mets and would fill a few needs for them, however, the Blue Jays are also interested in the former Astro and could swoop in and make a deal.
As 2020 comes to a close, Myrtle Beach, South Carolina is welcoming visitors with safe experiences, travel deals and the much anticipated opportunities to create memories together. With the holiday season underway, it's a magical season at the beach with not-to-miss travel savings, plenty of safe entertainment options, theatrical adventures, and an abundance of outdoor activities that can ensure your trip is one to remember.
PRESS RELEASE, Lund Sweden, December 1, 2020 - Active Biotech (NASDAQ STOCKHOLM: ACTI)In accordance with a decision made by the Annual General Meeting held on May 19, 2020, the Nomination Committee shall comprise the representatives for the three largest shareholders by votes, as per end of September 2020, and the Chairman of the Board. If a shareholder does not exercise its right to appoint a member, entitlement to appoint a member of the Nomination Committee transfers to the shareholder who is the next largest shareholder in terms of voting rights. Based on the above, the Nomination Committee is composed with participants representing the largest shareholders in Active Biotech at September 30 and consists of:Michael Shalmi, chairman Mats Arnhög, MGA Holding Per Colleen, 4:e AP Fonden Peter ThelinFor the 2021 Annual General Meeting, the Nomination Committee shall prepare and submit proposals regarding the Chairman of the AGM, the number of Board members, a Chairman and Board members elected by the AGM, the fees and other renumerations to Board members and Board committee´s, number of auditors, the auditor, fees to auditors and election of a Nomination Committee.For further information, please contact: Helén Tuvesson, CEO, +46 46 19 21 56, firstname.lastname@example.orgHans Kolam, CFO, +46 46 19 20 44, email@example.com About Active Biotech Active Biotech AB (publ) (Nasdaq Stockholm: ACTI) is a biotechnology company that deploys its extensive knowledge base and portfolio of compounds to develop first-in-class immunomodulatory treatments for specialist oncology and immunology indications with a high unmet medical need and significant commercial potential. Following a portfolio refocus, the business model of Active Biotech aims to advance projects to the clinical development phase and then further develop the programs internally or pursue in partnership. Active Biotech currently holds three projects in its portfolio: Naptumomab, a targeted anti-cancer immunotherapy, partnered to NeoTX Therapeutics, is in a Phase 1/2 clinical program in patients with advanced solid tumors. The small molecule immunomodulators, tasquinimod and laquinimod, both having a mode of actions that includes modulation of myeloid immune cell function, are targeted towards hematological malignancies and inflammatory eye disorders, respectively. Tasquinimod, is in clinical phase 1b/2a for treatment of multiple myeloma. Laquinimod is advancing to phase 2 for treatment of non-infectious uveitis during second half of 2021. Please visit www.activebiotech.com for more information.This information was submitted for publication, through the agency of the contact person set out above, at 16.45 p.m. CET on December 1, 2020.Attachment * 201201_Active Biotech’s nomination committee appointed
NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENTSAMPO PLC STOCK EXCHANGE RELEASE 1 December 2020 5:45 pmSampo plc announces final results of its cash tender offers in respect of its outstanding EUR 500,000,000 1.50 per cent. Notes due 16 September 2021, SEK 700,000,000 0.875 per cent. Notes due 23 May 2022, SEK 1,300,000,000 Floating Rate Notes due 23 May 2022, EUR 750,000,000 1.00 per cent. Notes due 18 September 2023 and EUR 500,000,000 1.250 per cent. Notes due 30 May 2025This announcement is released by Sampo plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (“MAR”), encompassing information relating to the 2021 Notes, 2022 Fixed Rate Notes, 2022 Floating Rate Notes, 2023 Notes and 2025 Notes described above (each as defined below). For the purposes of MAR and Article 2 of the Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Jarmo Salonen, the Head of Investor Relations and Group Communications of Sampo plc.Sampo plc (the “Issuer”) today announces the final results of its invitations to holders of its outstanding EUR 500,000,000 1.50 per cent. Notes due 16 September 2021 (ISIN: XS1110299036) (the “2021 Notes”), SEK 700,000,000 0.875 per cent. Notes due 23 May 2022 (ISIN: XS1823483414) (the “2022 Fixed Rate Notes”), SEK 1,300,000,000 Floating Rate Notes due 23 May 2022 (ISIN: XS1823484222) (the “2022 Floating Rate Notes”), EUR 750,000,000 1.00 per cent. Notes due 18 September 2023 (ISIN: XS1520733301) (the “2023 Notes”) and EUR 500,000,000 1.250 per cent. Notes due 30 May 2025 (ISIN: XS1622193750) (the “2025 Notes”) (together, the “Securities” and each series of Securities, a “Series”) to (i) tender any and all of their 2023 Notes and (ii) to tender their 2021 Notes, 2022 Fixed Rate Notes, 2022 Floating Rate Notes and 2025 Notes up to (subject as set out herein and allocated in the Issuer’s sole discretion) an aggregate principal amount of the Euro Equivalent of EUR 750,000,000 less the aggregate principal amount of the 2023 Notes validly tendered and accepted for purchase, in each case for purchase by the Issuer for cash.Such invitations (the “Tender Offers”) were announced on 23 November 2020 and were made on the terms and subject to the conditions contained in the tender offer memorandum dated 23 November 2020 (the “Tender Offer Memorandum”) prepared by the Issuer. Capitalised terms used and not otherwise defined in this announcement have the meanings given thereto in the Tender Offer Memorandum.Final Acceptance Amount and Pricing InformationAs at the Expiration Time, being 5.00 pm Central European time on 30 November 2020, the Issuer had received valid tenders for purchase pursuant to the Tender Offers of: (i) EUR 139,609,000 of the 2021 Notes; (ii) SEK 582,000,000 of the 2022 Fixed Rate Notes; (iii) SEK 1,050,000,000 of the 2022 Floating Rate Notes; (iv) EUR 228,448,000 of the 2023 Notes; and (v) EUR 127,161,000 of the 2025 Notes.The Issuer has decided to set the Final Acceptance Amount at EUR 654,974,480 (using the Applicable SEK/EUR Exchange Rate at SEK 1 = EUR 0.09789, where applicable). Pricing for the Tender Offers took place at or around 2.00 pm Central European time today.A summary of the final results of, and pricing for, each Series of Securities appears below:Any and all SecuritiesDescription of the SecuritiesEUR 750,000,000 1.00 per cent. Notes due 18 September 2023 ISINXS1520733301 Principal Amounts of the Securities Accepted for PurchaseEUR 228,448,000 Tender Price104.087% Accrued Interest0.205% Benchmark RateN/A Fixed Purchase SpreadN/A Fixed Purchase Yield-0.450% Scaling FactorN/A Capped Tender Offer SecuritiesDescription of the SecuritiesEUR 500,000,000 1.50 per cent. Notes due 16 September 2021SEK 700,000,000 0.875 per cent. Notes due 23 May 2022SEK 1,300,000,000 Floating Rate Notes due 23 May 2022EUR 500,000,000 1.250 per cent. Notes due 30 May 2025 ISINXS1110299036XS1823483414XS1823484222XS1622193750 Principal Amounts of the Securities Accepted for PurchaseEUR 139,609,000SEK 582,000,000SEK 1,050,000,000EUR 127,161,000 Tender Price101.586%101.365%101.073%106.773% Accrued Interest0.316%0.459%0.017%0.637% Benchmark RateN/AN/AN/AInterpolated Mid-Swap Rate of -0.482% Fixed Purchase SpreadN/AN/AN/A15 bps Fixed Purchase Yield-0.500%-0.050%N/A-0.332% Scaling FactorN/AN/AN/AN/A GeneralThe Settlement Date in respect of the Securities accepted for purchase pursuant to the Tender Offers is expected to be 2 December 2020.Following settlement of the Tender Offers, (i) EUR 360,391,000 of the 2021 Notes; (ii) SEK 118,000,000 of the 2022 Fixed Rate Notes; (iii) SEK 250,000,000 of the 2022 Floating Rate Notes; (iv) EUR 521,552,000 of the 2023 Notes; and (v) EUR 372,839,000 of the 2025 Notes will remain outstanding.The Issuer will also pay an Accrued Interest Payment in respect of Securities purchased pursuant to the Tender Offers as set out in the table above.Contact informationDealer Managers for the Tender Offers:Citigroup Global Markets Limited Telephone: +44 20 7986 8969 Attention: Liability Management Group Email: firstname.lastname@example.orgNordea Bank Abp Telephone: +45 61612996 Attention: Nordea Liability Management Email: email@example.comTender Agent for the Tender Offers:Lucid Issuer Services Limited Telephone: +44 20 7704 0880 Attention: Paul Kamminga Email: firstname.lastname@example.orgIssuer:SAMPO PLCJarmo Salonen Head of Investor Relations and Group Communications Telephone: +358 10 516 0030 Email: email@example.com DISCLAIMER:The offer period for the Offers has now expired. No further tenders of any Securities may be made pursuant to the Tender Offers. This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Issuer, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.Distribution: Nasdaq Helsinki London Stock Exchange The principal media Financial Supervisory Authority www.sampo.com
The "Europe 3D Cell Culture Market By Product (Scaffold-Based 3D Cell Cultures, Scaffold-Free 3D Cell Cultures, Microfluidics, Magnetic Levitation), By End User (Pharmaceutical & Biotechnology Companies, Others), By Application, By Country, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.
* McKinley Oswald, VERB’s President of Global Sales, provided a winning demo of VERB’s livestream ecommerce and webinar offering, verbLIVE, in a medical device sales setting * verbLIVE demo chosen by a live virtual audience of clients and AppExchange PartnersNEWPORT BEACH, Calif. and SALT LAKE CITY, Dec. 01, 2020 (GLOBE NEWSWIRE) -- VERB Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), a leader in interactive video-based sales enablement applications, including interactive livestream ecommerce, webinar, CRM and marketing applications for entrepreneurs and enterprises, today announced that it won Salesforce’s November AppExchange Demo Jam competition.Demo Jam, which began in 2015, is a monthly, gameshow-style event where participating Salesforce AppExchange partners demonstrate their technology in three minutes before a live virtual audience that votes for their favorite demo. For November 2020, Demo Jam’s theme was “Productivity Apps” and featured five other companies in addition to VERB: Adobe, Prolifiq, Seismic, Smartsheet, and Mockup Components. A replay of the event can be viewed here at November Demo Jam; VERB’s demo begins at the 27:38 mark.McKinley Oswald, VERB’s President of Global Sales, provided a demo of VERB’s livestream ecommerce and webinar offering, verbLIVE, on the Salesforce platform. His presentation demonstrated how easily and seamlessly verbLIVE can be launched from Salesforce, invite their leads and contacts, and then host a live meeting. He simulated a livestreamed medical device sales meeting, highlighting the interactive features Salesforce users can leverage, including links for additional product explainer videos, calendars to set up appointments for questions and follow-ups and a web page that opens up a 3D view of the device. Other key features described included the ability to see questions of meeting participants and the generation of analytics reports summarizing each participant’s interaction during the meeting – all purpose-built for a friction-free sales environment that enhances the salesperson’s productivity.“We are thrilled to have earned this recognition from clients and our AppExchange Partner peers,” said Rory J. Cutaia, VERB CEO. “We fully integrated verbLIVE into the Salesforce platform in July, and while we only just made it available on the AppExchange marketplace in August, we have already gained significant traction in the form of user downloads from Salesforce users. Approximately 75% of clients of our medical sales enablement business from the recent SoloFire acquisition, which McKinley used for this demo, are on the Salesforce platform, giving us a tremendous opportunity to leverage this strong Salesforce user base and meaningfully grow the number of verbLIVE users.”About VERB VERB Technology Company, Inc. (NASDAQ: VERB) transforms how businesses attract and engage customers. The Company’s Software-as-a-Service, or SaaS, platform is based on its proprietary interactive video technology, and comprises a suite of sales enablement business software products offered on a subscription basis. Its software applications are available in over 60 countries and in more than 48 languages to large enterprise and small business sales teams that need affordable, easy-to-use, and quick-to-get-results sales tools. Available in both mobile and desktop versions, the applications are offered as a fully integrated suite, as well as on a standalone basis, and include verbCRM (Customer Relationship Management application), verbLEARN (Learning Management System application), and verbLIVE (Interactive Livestream eCommerce and Video Webinar application). The Company has offices in California and Utah. For more information, please visit: www.verb.tech.FORWARD LOOKING STATEMENTS This press release contains forward-looking statements that involve risks and uncertainties, including statements about the closing of the offering of common stock. These forward-looking statements involve risks and uncertainties. If any of these risks or uncertainties materialize, or if any of our assumptions prove incorrect, our actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include risks associated with: the COVID-19 pandemic and related public health measures on our business, customers, markets and the worldwide economy; our plans to attract new customers, retain existing customers and increase our annual revenue; the development and delivery of new products, including verbLIVE; our plans and expectations regarding software-as-a-service offerings; our ability to execute on, integrate, and realize the benefits of any acquisitions; fluctuations in our quarterly results of operations and other operating measures; increasing competition; general economic, market and business conditions; and the risks described in the filings that we make with the Securities and Exchange Commission (“SEC”) from time to time, including the risks described under the headings “Risk Factors” and “Management Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K, which was filed with the SEC on May 14, 2020, as amended by Amendment No. 1 on Form 10-K/A to our Annual Report on Form 10-K, which was filed with the SEC on June 4, 2020, and which should be read in conjunction with our financial results and forward-looking statements contained therein, and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, which was filed with the SEC on May 15, 2020, as amended by Amendment No. 1 on Form 10-Q/A to our Quarterly Report on Form 10-Q, which was filed with the SEC on June 4, 2020, and which should be read in conjunction with our financial results and forward-looking statements contained therein. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.Investor Relations: 888.504.9929 firstname.lastname@example.orgMedia Contact: 855.250.2300, ext.107 email@example.com
Staff watched and labelled films and series, then fed the data to an algorithm to generate an age rating.
The ad hoc $900 billion bill could increase pressure on leaders to reach a compromise after months of stalled negotiations on another relief package.